Company intelligence / Profile preview
Changchun Lanjiang Pharmaceutical Technology
Changchun, Jilin, Chinalanjiangpharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Changchun Lanjiang Pharmaceutical Technology is a clinical-stage biotechnology company based in Changchun, China, specializing in the discovery and development of innovative small molecule therapeutics. Established in 2013, the company focuses primarily on metabolic and endocrine disorders, including type 2 diabetes and hyperuricemia. Its lead program, LJ-101, is a GPR119 agonist currently in Phase 2 clinical trials for diabetes management. Additionally, the company is advancing LJ-401, a URAT1 inhibitor for the treatment of gout and hyperuricemia, alongside other early-stage metabolic programs.
- Therapeutic areas
- EndocrinologyRheumatologyCardiovascularMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Changchun Lanjiang Pharmaceutical Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Changchun Lanjiang Pharmaceutical Technology.